In addition to Wegovy, incretin mimetics FDA-approved for chronic weight management include Saxenda (liraglutide), also made by Novo Nordisk, and Zepbound (tirzepatide), produced by Fortune 500 firm Eli Lilly & Co
In the SELECT trial, semaglutide reduced the incidence of major adverse cardiovascular events, including heart attack and stroke, by 20% in individuals with established cardiovascular disease and obesity but without diabetes [10]
Urology 124 , 310.e9310.e14 (2019)
Talk to your doctor or Registered Dietitian about your risk factors, blood test results, and diet to see if these supplements are right for you.
This is the moment where most researchers get stuck